Autologous tolerogenic dendritic cells

· Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Autologous tolerogenic dendritic cells, covering 2025-12-02 to 2025-12-02. Get the full timeline:

Most recent: Clinical Trial Update: The Treatment of Patients With Type 1 Diabetes Mellitus With Autologous Tolerogenic Dendritic Cells [Phase 1, Phase 2]

See pricing